nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—Tachycardia—Niacin—coronary artery disease	0.00141	0.00248	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Trandolapril—coronary artery disease	0.00141	0.00247	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Enalapril—coronary artery disease	0.00141	0.00246	CcSEcCtD
Methylscopolamine bromide—Vomiting—Ticagrelor—coronary artery disease	0.00141	0.00246	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Clopidogrel—coronary artery disease	0.0014	0.00245	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Losartan—coronary artery disease	0.00139	0.00244	CcSEcCtD
Methylscopolamine bromide—Palpitations—Perindopril—coronary artery disease	0.00139	0.00244	CcSEcCtD
Methylscopolamine bromide—Confusional state—Enalapril—coronary artery disease	0.00139	0.00244	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Lovastatin—coronary artery disease	0.00139	0.00243	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Telmisartan—coronary artery disease	0.00139	0.00243	CcSEcCtD
Methylscopolamine bromide—Headache—Ticagrelor—coronary artery disease	0.00138	0.00243	CcSEcCtD
Methylscopolamine bromide—Constipation—Eplerenone—coronary artery disease	0.00138	0.00242	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Enalapril—coronary artery disease	0.00138	0.00242	CcSEcCtD
Methylscopolamine bromide—Urticaria—Fenofibrate—coronary artery disease	0.00137	0.0024	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Ezetimibe—coronary artery disease	0.00136	0.00239	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Telmisartan—coronary artery disease	0.00136	0.00238	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Trandolapril—coronary artery disease	0.00135	0.00237	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Captopril—coronary artery disease	0.00135	0.00236	CcSEcCtD
Methylscopolamine bromide—Constipation—Simvastatin—coronary artery disease	0.00135	0.00236	CcSEcCtD
Methylscopolamine bromide—Urticaria—Clopidogrel—coronary artery disease	0.00135	0.00236	CcSEcCtD
Methylscopolamine bromide—Insomnia—Valsartan—coronary artery disease	0.00135	0.00236	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Enalapril—coronary artery disease	0.00135	0.00236	CcSEcCtD
Methylscopolamine bromide—Nausea—Gemfibrozil—coronary artery disease	0.00134	0.00235	CcSEcCtD
Methylscopolamine bromide—Insomnia—Olmesartan—coronary artery disease	0.00134	0.00235	CcSEcCtD
Methylscopolamine bromide—Urticaria—Lovastatin—coronary artery disease	0.00134	0.00235	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Eplerenone—coronary artery disease	0.00133	0.00234	CcSEcCtD
Methylscopolamine bromide—Confusional state—Captopril—coronary artery disease	0.00133	0.00234	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Telmisartan—coronary artery disease	0.00133	0.00232	CcSEcCtD
Methylscopolamine bromide—Somnolence—Valsartan—coronary artery disease	0.00132	0.00232	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Captopril—coronary artery disease	0.00132	0.00232	CcSEcCtD
Methylscopolamine bromide—Dizziness—Rosuvastatin—coronary artery disease	0.00132	0.0023	CcSEcCtD
Methylscopolamine bromide—Urticaria—Ezetimibe—coronary artery disease	0.00131	0.0023	CcSEcCtD
Methylscopolamine bromide—Nausea—Ticagrelor—coronary artery disease	0.00131	0.0023	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Perindopril—coronary artery disease	0.00131	0.00229	CcSEcCtD
Methylscopolamine bromide—Insomnia—Niacin—coronary artery disease	0.00131	0.00229	CcSEcCtD
Methylscopolamine bromide—Palpitations—Losartan—coronary artery disease	0.0013	0.00228	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Simvastatin—coronary artery disease	0.0013	0.00228	CcSEcCtD
Methylscopolamine bromide—Confusional state—Perindopril—coronary artery disease	0.00129	0.00227	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Captopril—coronary artery disease	0.00129	0.00226	CcSEcCtD
Methylscopolamine bromide—Insomnia—Pravastatin—coronary artery disease	0.00129	0.00226	CcSEcCtD
Methylscopolamine bromide—Somnolence—Niacin—coronary artery disease	0.00129	0.00225	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Perindopril—coronary artery disease	0.00128	0.00225	CcSEcCtD
Methylscopolamine bromide—Dizziness—Acetylsalicylic acid—coronary artery disease	0.00128	0.00224	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Furosemide—coronary artery disease	0.00127	0.00223	CcSEcCtD
Methylscopolamine bromide—Constipation—Valsartan—coronary artery disease	0.00127	0.00223	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Fenofibrate—coronary artery disease	0.00127	0.00223	CcSEcCtD
Methylscopolamine bromide—Constipation—Olmesartan—coronary artery disease	0.00127	0.00222	CcSEcCtD
Methylscopolamine bromide—Confusional state—Furosemide—coronary artery disease	0.00126	0.0022	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Perindopril—coronary artery disease	0.00125	0.0022	CcSEcCtD
Methylscopolamine bromide—Urticaria—Simvastatin—coronary artery disease	0.00125	0.00219	CcSEcCtD
Methylscopolamine bromide—Insomnia—Trandolapril—coronary artery disease	0.00125	0.00219	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Clopidogrel—coronary artery disease	0.00125	0.00219	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Furosemide—coronary artery disease	0.00125	0.00219	CcSEcCtD
Methylscopolamine bromide—Insomnia—Enalapril—coronary artery disease	0.00125	0.00218	CcSEcCtD
Methylscopolamine bromide—Headache—Rosuvastatin—coronary artery disease	0.00125	0.00218	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Lovastatin—coronary artery disease	0.00124	0.00218	CcSEcCtD
Methylscopolamine bromide—Tension—Ramipril—coronary artery disease	0.00124	0.00217	CcSEcCtD
Methylscopolamine bromide—Asthenia—Fenofibrate—coronary artery disease	0.00124	0.00217	CcSEcCtD
Methylscopolamine bromide—Somnolence—Trandolapril—coronary artery disease	0.00123	0.00216	CcSEcCtD
Methylscopolamine bromide—Insomnia—Telmisartan—coronary artery disease	0.00123	0.00215	CcSEcCtD
Methylscopolamine bromide—Nervousness—Ramipril—coronary artery disease	0.00123	0.00215	CcSEcCtD
Methylscopolamine bromide—Vomiting—Acetylsalicylic acid—coronary artery disease	0.00123	0.00215	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Losartan—coronary artery disease	0.00123	0.00215	CcSEcCtD
Methylscopolamine bromide—Somnolence—Enalapril—coronary artery disease	0.00123	0.00215	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Olmesartan—coronary artery disease	0.00122	0.00214	CcSEcCtD
Methylscopolamine bromide—Constipation—Pravastatin—coronary artery disease	0.00122	0.00214	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Ezetimibe—coronary artery disease	0.00122	0.00213	CcSEcCtD
Methylscopolamine bromide—Asthenia—Clopidogrel—coronary artery disease	0.00122	0.00213	CcSEcCtD
Methylscopolamine bromide—Confusional state—Losartan—coronary artery disease	0.00121	0.00213	CcSEcCtD
Methylscopolamine bromide—Tension—Timolol—coronary artery disease	0.00121	0.00213	CcSEcCtD
Methylscopolamine bromide—Asthenia—Lovastatin—coronary artery disease	0.00121	0.00212	CcSEcCtD
Methylscopolamine bromide—Somnolence—Telmisartan—coronary artery disease	0.00121	0.00212	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Losartan—coronary artery disease	0.0012	0.00211	CcSEcCtD
Methylscopolamine bromide—Nervousness—Timolol—coronary artery disease	0.0012	0.0021	CcSEcCtD
Methylscopolamine bromide—Insomnia—Captopril—coronary artery disease	0.0012	0.0021	CcSEcCtD
Methylscopolamine bromide—Asthenia—Ezetimibe—coronary artery disease	0.00119	0.00208	CcSEcCtD
Methylscopolamine bromide—Constipation—Trandolapril—coronary artery disease	0.00118	0.00207	CcSEcCtD
Methylscopolamine bromide—Urticaria—Valsartan—coronary artery disease	0.00118	0.00207	CcSEcCtD
Methylscopolamine bromide—Nausea—Rosuvastatin—coronary artery disease	0.00118	0.00207	CcSEcCtD
Methylscopolamine bromide—Constipation—Enalapril—coronary artery disease	0.00118	0.00207	CcSEcCtD
Methylscopolamine bromide—Urticaria—Olmesartan—coronary artery disease	0.00118	0.00206	CcSEcCtD
Methylscopolamine bromide—Somnolence—Captopril—coronary artery disease	0.00118	0.00206	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Losartan—coronary artery disease	0.00118	0.00206	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Pravastatin—coronary artery disease	0.00117	0.00206	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Timolol—coronary artery disease	0.00117	0.00204	CcSEcCtD
Methylscopolamine bromide—Constipation—Telmisartan—coronary artery disease	0.00116	0.00204	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Simvastatin—coronary artery disease	0.00116	0.00203	CcSEcCtD
Methylscopolamine bromide—Insomnia—Perindopril—coronary artery disease	0.00116	0.00203	CcSEcCtD
Methylscopolamine bromide—Asthenia—Eplerenone—coronary artery disease	0.00116	0.00203	CcSEcCtD
Methylscopolamine bromide—Urticaria—Niacin—coronary artery disease	0.00115	0.00201	CcSEcCtD
Methylscopolamine bromide—Nausea—Acetylsalicylic acid—coronary artery disease	0.00115	0.00201	CcSEcCtD
Methylscopolamine bromide—Dizziness—Fenofibrate—coronary artery disease	0.00114	0.002	CcSEcCtD
Methylscopolamine bromide—Somnolence—Perindopril—coronary artery disease	0.00114	0.002	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Trandolapril—coronary artery disease	0.00114	0.002	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Enalapril—coronary artery disease	0.00114	0.00199	CcSEcCtD
Methylscopolamine bromide—Urticaria—Pravastatin—coronary artery disease	0.00113	0.00198	CcSEcCtD
Methylscopolamine bromide—Asthenia—Simvastatin—coronary artery disease	0.00113	0.00198	CcSEcCtD
Methylscopolamine bromide—Constipation—Captopril—coronary artery disease	0.00113	0.00198	CcSEcCtD
Methylscopolamine bromide—Tension—Lisinopril—coronary artery disease	0.00113	0.00197	CcSEcCtD
Methylscopolamine bromide—Dizziness—Clopidogrel—coronary artery disease	0.00112	0.00197	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Telmisartan—coronary artery disease	0.00112	0.00196	CcSEcCtD
Methylscopolamine bromide—Palpitations—Ramipril—coronary artery disease	0.00112	0.00196	CcSEcCtD
Methylscopolamine bromide—Dizziness—Lovastatin—coronary artery disease	0.00111	0.00195	CcSEcCtD
Methylscopolamine bromide—Nervousness—Lisinopril—coronary artery disease	0.00111	0.00195	CcSEcCtD
Methylscopolamine bromide—Somnolence—Furosemide—coronary artery disease	0.00111	0.00194	CcSEcCtD
Methylscopolamine bromide—Urticaria—Trandolapril—coronary artery disease	0.0011	0.00193	CcSEcCtD
Methylscopolamine bromide—Constipation—Perindopril—coronary artery disease	0.0011	0.00192	CcSEcCtD
Methylscopolamine bromide—Vomiting—Fenofibrate—coronary artery disease	0.0011	0.00192	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Valsartan—coronary artery disease	0.0011	0.00192	CcSEcCtD
Methylscopolamine bromide—Urticaria—Enalapril—coronary artery disease	0.0011	0.00192	CcSEcCtD
Methylscopolamine bromide—Dizziness—Ezetimibe—coronary artery disease	0.00109	0.00192	CcSEcCtD
Methylscopolamine bromide—Palpitations—Timolol—coronary artery disease	0.00109	0.00191	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Captopril—coronary artery disease	0.00109	0.00191	CcSEcCtD
Methylscopolamine bromide—Insomnia—Losartan—coronary artery disease	0.00109	0.00191	CcSEcCtD
Methylscopolamine bromide—Headache—Fenofibrate—coronary artery disease	0.00108	0.00189	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Lisinopril—coronary artery disease	0.00108	0.00189	CcSEcCtD
Methylscopolamine bromide—Urticaria—Telmisartan—coronary artery disease	0.00108	0.00189	CcSEcCtD
Methylscopolamine bromide—Vomiting—Clopidogrel—coronary artery disease	0.00108	0.00189	CcSEcCtD
Methylscopolamine bromide—Vomiting—Lovastatin—coronary artery disease	0.00107	0.00188	CcSEcCtD
Methylscopolamine bromide—Somnolence—Losartan—coronary artery disease	0.00107	0.00188	CcSEcCtD
Methylscopolamine bromide—Dizziness—Eplerenone—coronary artery disease	0.00107	0.00187	CcSEcCtD
Methylscopolamine bromide—Asthenia—Valsartan—coronary artery disease	0.00107	0.00187	CcSEcCtD
Methylscopolamine bromide—Constipation—Furosemide—coronary artery disease	0.00107	0.00187	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Niacin—coronary artery disease	0.00107	0.00187	CcSEcCtD
Methylscopolamine bromide—Asthenia—Olmesartan—coronary artery disease	0.00106	0.00186	CcSEcCtD
Methylscopolamine bromide—Headache—Clopidogrel—coronary artery disease	0.00106	0.00186	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Perindopril—coronary artery disease	0.00106	0.00185	CcSEcCtD
Methylscopolamine bromide—Headache—Lovastatin—coronary artery disease	0.00106	0.00185	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Ramipril—coronary artery disease	0.00105	0.00185	CcSEcCtD
Methylscopolamine bromide—Vomiting—Ezetimibe—coronary artery disease	0.00105	0.00184	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Pravastatin—coronary artery disease	0.00105	0.00184	CcSEcCtD
Methylscopolamine bromide—Dizziness—Simvastatin—coronary artery disease	0.00104	0.00183	CcSEcCtD
Methylscopolamine bromide—Confusional state—Ramipril—coronary artery disease	0.00104	0.00182	CcSEcCtD
Methylscopolamine bromide—Asthenia—Niacin—coronary artery disease	0.00104	0.00182	CcSEcCtD
Methylscopolamine bromide—Headache—Ezetimibe—coronary artery disease	0.00104	0.00181	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Ramipril—coronary artery disease	0.00103	0.00181	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Timolol—coronary artery disease	0.00103	0.0018	CcSEcCtD
Methylscopolamine bromide—Constipation—Losartan—coronary artery disease	0.00103	0.0018	CcSEcCtD
Methylscopolamine bromide—Vomiting—Eplerenone—coronary artery disease	0.00103	0.0018	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Furosemide—coronary artery disease	0.00103	0.0018	CcSEcCtD
Methylscopolamine bromide—Nausea—Fenofibrate—coronary artery disease	0.00103	0.0018	CcSEcCtD
Methylscopolamine bromide—Asthenia—Pravastatin—coronary artery disease	0.00102	0.00179	CcSEcCtD
Methylscopolamine bromide—Urticaria—Perindopril—coronary artery disease	0.00102	0.00179	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Trandolapril—coronary artery disease	0.00102	0.00179	CcSEcCtD
Methylscopolamine bromide—Confusional state—Timolol—coronary artery disease	0.00102	0.00178	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Enalapril—coronary artery disease	0.00102	0.00178	CcSEcCtD
Methylscopolamine bromide—Palpitations—Lisinopril—coronary artery disease	0.00101	0.00178	CcSEcCtD
Methylscopolamine bromide—Headache—Eplerenone—coronary artery disease	0.00101	0.00178	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Timolol—coronary artery disease	0.00101	0.00177	CcSEcCtD
Methylscopolamine bromide—Nausea—Clopidogrel—coronary artery disease	0.00101	0.00177	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Ramipril—coronary artery disease	0.00101	0.00177	CcSEcCtD
Methylscopolamine bromide—Vomiting—Simvastatin—coronary artery disease	0.001	0.00176	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Telmisartan—coronary artery disease	0.001	0.00176	CcSEcCtD
Methylscopolamine bromide—Nausea—Lovastatin—coronary artery disease	0.001	0.00175	CcSEcCtD
Methylscopolamine bromide—Asthenia—Trandolapril—coronary artery disease	0.000993	0.00174	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Losartan—coronary artery disease	0.000992	0.00174	CcSEcCtD
Methylscopolamine bromide—Urticaria—Furosemide—coronary artery disease	0.000992	0.00174	CcSEcCtD
Methylscopolamine bromide—Asthenia—Enalapril—coronary artery disease	0.000989	0.00173	CcSEcCtD
Methylscopolamine bromide—Headache—Simvastatin—coronary artery disease	0.000988	0.00173	CcSEcCtD
Methylscopolamine bromide—Dizziness—Valsartan—coronary artery disease	0.000985	0.00172	CcSEcCtD
Methylscopolamine bromide—Nausea—Ezetimibe—coronary artery disease	0.000982	0.00172	CcSEcCtD
Methylscopolamine bromide—Dizziness—Olmesartan—coronary artery disease	0.00098	0.00172	CcSEcCtD
Methylscopolamine bromide—Asthenia—Telmisartan—coronary artery disease	0.000976	0.00171	CcSEcCtD
Methylscopolamine bromide—Nausea—Eplerenone—coronary artery disease	0.000961	0.00168	CcSEcCtD
Methylscopolamine bromide—Dizziness—Niacin—coronary artery disease	0.000957	0.00168	CcSEcCtD
Methylscopolamine bromide—Urticaria—Losartan—coronary artery disease	0.000957	0.00168	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Lisinopril—coronary artery disease	0.000955	0.00167	CcSEcCtD
Methylscopolamine bromide—Asthenia—Captopril—coronary artery disease	0.000949	0.00166	CcSEcCtD
Methylscopolamine bromide—Vomiting—Valsartan—coronary artery disease	0.000947	0.00166	CcSEcCtD
Methylscopolamine bromide—Confusional state—Lisinopril—coronary artery disease	0.000944	0.00165	CcSEcCtD
Methylscopolamine bromide—Dizziness—Pravastatin—coronary artery disease	0.000943	0.00165	CcSEcCtD
Methylscopolamine bromide—Vomiting—Olmesartan—coronary artery disease	0.000942	0.00165	CcSEcCtD
Methylscopolamine bromide—Nausea—Simvastatin—coronary artery disease	0.000937	0.00164	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Lisinopril—coronary artery disease	0.000937	0.00164	CcSEcCtD
Methylscopolamine bromide—Insomnia—Ramipril—coronary artery disease	0.000934	0.00164	CcSEcCtD
Methylscopolamine bromide—Headache—Valsartan—coronary artery disease	0.000933	0.00163	CcSEcCtD
Methylscopolamine bromide—Headache—Olmesartan—coronary artery disease	0.000928	0.00163	CcSEcCtD
Methylscopolamine bromide—Asthenia—Perindopril—coronary artery disease	0.000921	0.00161	CcSEcCtD
Methylscopolamine bromide—Vomiting—Niacin—coronary artery disease	0.000921	0.00161	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Furosemide—coronary artery disease	0.00092	0.00161	CcSEcCtD
Methylscopolamine bromide—Somnolence—Ramipril—coronary artery disease	0.000918	0.00161	CcSEcCtD
Methylscopolamine bromide—Dizziness—Trandolapril—coronary artery disease	0.000915	0.0016	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Lisinopril—coronary artery disease	0.000914	0.0016	CcSEcCtD
Methylscopolamine bromide—Insomnia—Timolol—coronary artery disease	0.000913	0.0016	CcSEcCtD
Methylscopolamine bromide—Dizziness—Enalapril—coronary artery disease	0.000912	0.0016	CcSEcCtD
Methylscopolamine bromide—Headache—Niacin—coronary artery disease	0.000907	0.00159	CcSEcCtD
Methylscopolamine bromide—Vomiting—Pravastatin—coronary artery disease	0.000906	0.00159	CcSEcCtD
Methylscopolamine bromide—Dizziness—Telmisartan—coronary artery disease	0.000899	0.00158	CcSEcCtD
Methylscopolamine bromide—Somnolence—Timolol—coronary artery disease	0.000898	0.00157	CcSEcCtD
Methylscopolamine bromide—Asthenia—Furosemide—coronary artery disease	0.000896	0.00157	CcSEcCtD
Methylscopolamine bromide—Headache—Pravastatin—coronary artery disease	0.000893	0.00156	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Losartan—coronary artery disease	0.000887	0.00155	CcSEcCtD
Methylscopolamine bromide—Nausea—Valsartan—coronary artery disease	0.000885	0.00155	CcSEcCtD
Methylscopolamine bromide—Constipation—Ramipril—coronary artery disease	0.000883	0.00155	CcSEcCtD
Methylscopolamine bromide—Nausea—Olmesartan—coronary artery disease	0.00088	0.00154	CcSEcCtD
Methylscopolamine bromide—Vomiting—Trandolapril—coronary artery disease	0.00088	0.00154	CcSEcCtD
Methylscopolamine bromide—Vomiting—Enalapril—coronary artery disease	0.000877	0.00154	CcSEcCtD
Methylscopolamine bromide—Dizziness—Captopril—coronary artery disease	0.000875	0.00153	CcSEcCtD
Methylscopolamine bromide—Headache—Trandolapril—coronary artery disease	0.000867	0.00152	CcSEcCtD
Methylscopolamine bromide—Vomiting—Telmisartan—coronary artery disease	0.000865	0.00151	CcSEcCtD
Methylscopolamine bromide—Asthenia—Losartan—coronary artery disease	0.000864	0.00151	CcSEcCtD
Methylscopolamine bromide—Headache—Enalapril—coronary artery disease	0.000864	0.00151	CcSEcCtD
Methylscopolamine bromide—Nausea—Niacin—coronary artery disease	0.00086	0.00151	CcSEcCtD
Methylscopolamine bromide—Headache—Telmisartan—coronary artery disease	0.000852	0.00149	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Ramipril—coronary artery disease	0.000851	0.00149	CcSEcCtD
Methylscopolamine bromide—Dizziness—Perindopril—coronary artery disease	0.000849	0.00149	CcSEcCtD
Methylscopolamine bromide—Insomnia—Lisinopril—coronary artery disease	0.000847	0.00148	CcSEcCtD
Methylscopolamine bromide—Nausea—Pravastatin—coronary artery disease	0.000847	0.00148	CcSEcCtD
Methylscopolamine bromide—Vomiting—Captopril—coronary artery disease	0.000841	0.00147	CcSEcCtD
Methylscopolamine bromide—Somnolence—Lisinopril—coronary artery disease	0.000833	0.00146	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Timolol—coronary artery disease	0.000832	0.00146	CcSEcCtD
Methylscopolamine bromide—Headache—Captopril—coronary artery disease	0.000828	0.00145	CcSEcCtD
Methylscopolamine bromide—Dizziness—Furosemide—coronary artery disease	0.000825	0.00145	CcSEcCtD
Methylscopolamine bromide—Nausea—Trandolapril—coronary artery disease	0.000822	0.00144	CcSEcCtD
Methylscopolamine bromide—Urticaria—Ramipril—coronary artery disease	0.00082	0.00144	CcSEcCtD
Methylscopolamine bromide—Nausea—Enalapril—coronary artery disease	0.000819	0.00143	CcSEcCtD
Methylscopolamine bromide—Vomiting—Perindopril—coronary artery disease	0.000816	0.00143	CcSEcCtD
Methylscopolamine bromide—Nausea—Telmisartan—coronary artery disease	0.000808	0.00142	CcSEcCtD
Methylscopolamine bromide—Headache—Perindopril—coronary artery disease	0.000804	0.00141	CcSEcCtD
Methylscopolamine bromide—Urticaria—Timolol—coronary artery disease	0.000802	0.0014	CcSEcCtD
Methylscopolamine bromide—Constipation—Lisinopril—coronary artery disease	0.000801	0.0014	CcSEcCtD
Methylscopolamine bromide—Dizziness—Losartan—coronary artery disease	0.000796	0.0014	CcSEcCtD
Methylscopolamine bromide—Vomiting—Furosemide—coronary artery disease	0.000794	0.00139	CcSEcCtD
Methylscopolamine bromide—Nausea—Captopril—coronary artery disease	0.000786	0.00138	CcSEcCtD
Methylscopolamine bromide—Headache—Furosemide—coronary artery disease	0.000782	0.00137	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Lisinopril—coronary artery disease	0.000772	0.00135	CcSEcCtD
Methylscopolamine bromide—Vomiting—Losartan—coronary artery disease	0.000766	0.00134	CcSEcCtD
Methylscopolamine bromide—Nausea—Perindopril—coronary artery disease	0.000763	0.00134	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Ramipril—coronary artery disease	0.000761	0.00133	CcSEcCtD
Methylscopolamine bromide—Headache—Losartan—coronary artery disease	0.000754	0.00132	CcSEcCtD
Methylscopolamine bromide—Urticaria—Lisinopril—coronary artery disease	0.000744	0.0013	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Timolol—coronary artery disease	0.000744	0.0013	CcSEcCtD
Methylscopolamine bromide—Nausea—Furosemide—coronary artery disease	0.000741	0.0013	CcSEcCtD
Methylscopolamine bromide—Asthenia—Ramipril—coronary artery disease	0.000741	0.0013	CcSEcCtD
Methylscopolamine bromide—Asthenia—Timolol—coronary artery disease	0.000724	0.00127	CcSEcCtD
Methylscopolamine bromide—Nausea—Losartan—coronary artery disease	0.000715	0.00125	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Lisinopril—coronary artery disease	0.00069	0.00121	CcSEcCtD
Methylscopolamine bromide—Dizziness—Ramipril—coronary artery disease	0.000683	0.0012	CcSEcCtD
Methylscopolamine bromide—Asthenia—Lisinopril—coronary artery disease	0.000672	0.00118	CcSEcCtD
Methylscopolamine bromide—Dizziness—Timolol—coronary artery disease	0.000668	0.00117	CcSEcCtD
Methylscopolamine bromide—Vomiting—Ramipril—coronary artery disease	0.000657	0.00115	CcSEcCtD
Methylscopolamine bromide—Headache—Ramipril—coronary artery disease	0.000647	0.00113	CcSEcCtD
Methylscopolamine bromide—Vomiting—Timolol—coronary artery disease	0.000642	0.00112	CcSEcCtD
Methylscopolamine bromide—Headache—Timolol—coronary artery disease	0.000632	0.00111	CcSEcCtD
Methylscopolamine bromide—Dizziness—Lisinopril—coronary artery disease	0.000619	0.00108	CcSEcCtD
Methylscopolamine bromide—Nausea—Ramipril—coronary artery disease	0.000613	0.00107	CcSEcCtD
Methylscopolamine bromide—Nausea—Timolol—coronary artery disease	0.0006	0.00105	CcSEcCtD
Methylscopolamine bromide—Vomiting—Lisinopril—coronary artery disease	0.000595	0.00104	CcSEcCtD
Methylscopolamine bromide—Headache—Lisinopril—coronary artery disease	0.000587	0.00103	CcSEcCtD
Methylscopolamine bromide—Nausea—Lisinopril—coronary artery disease	0.000556	0.000974	CcSEcCtD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCL10—coronary artery disease	3.72e-05	8.67e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PLG—coronary artery disease	3.71e-05	8.65e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCL2—coronary artery disease	3.7e-05	8.62e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—APOA1—coronary artery disease	3.7e-05	8.62e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL6R—coronary artery disease	3.69e-05	8.6e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCL10—coronary artery disease	3.68e-05	8.59e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PLG—coronary artery disease	3.67e-05	8.56e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—KDR—coronary artery disease	3.66e-05	8.54e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GPX1—coronary artery disease	3.65e-05	8.52e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MAPK14—coronary artery disease	3.64e-05	8.48e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ADRB2—coronary artery disease	3.62e-05	8.45e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ADRB2—coronary artery disease	3.61e-05	8.42e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PRKCE—coronary artery disease	3.58e-05	8.34e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ADRB2—coronary artery disease	3.58e-05	8.34e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—JAK2—coronary artery disease	3.57e-05	8.33e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—ESR1—coronary artery disease	3.57e-05	8.32e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SOCS1—coronary artery disease	3.57e-05	8.32e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PRKCE—coronary artery disease	3.57e-05	8.31e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—JAK2—coronary artery disease	3.56e-05	8.3e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—S100B—coronary artery disease	3.56e-05	8.3e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CD36—coronary artery disease	3.56e-05	8.29e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SOCS1—coronary artery disease	3.56e-05	8.29e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—S100B—coronary artery disease	3.55e-05	8.27e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PRKCE—coronary artery disease	3.53e-05	8.23e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—JAK2—coronary artery disease	3.53e-05	8.22e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—F2—coronary artery disease	3.53e-05	8.22e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—FN1—coronary artery disease	3.53e-05	8.22e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SOCS3—coronary artery disease	3.53e-05	8.22e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SOCS1—coronary artery disease	3.52e-05	8.21e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PPP2CA—coronary artery disease	3.51e-05	8.19e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—S100B—coronary artery disease	3.51e-05	8.19e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SOCS3—coronary artery disease	3.51e-05	8.19e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6ST—coronary artery disease	3.51e-05	8.19e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NFKBIA—coronary artery disease	3.49e-05	8.12e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TGFBR2—coronary artery disease	3.48e-05	8.12e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—KITLG—coronary artery disease	3.48e-05	8.12e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SOCS3—coronary artery disease	3.48e-05	8.11e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—KITLG—coronary artery disease	3.47e-05	8.09e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TGFBR2—coronary artery disease	3.47e-05	8.09e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TGFBR2—coronary artery disease	3.44e-05	8.01e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—KITLG—coronary artery disease	3.44e-05	8.01e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—STAT5A—coronary artery disease	3.4e-05	7.93e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MMP3—coronary artery disease	3.4e-05	7.93e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MMP3—coronary artery disease	3.39e-05	7.91e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—STAT5A—coronary artery disease	3.39e-05	7.91e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—KIT—coronary artery disease	3.38e-05	7.87e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—MTHFR—coronary artery disease	3.37e-05	7.86e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—STAT5A—coronary artery disease	3.36e-05	7.83e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MMP3—coronary artery disease	3.36e-05	7.83e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOB—coronary artery disease	3.29e-05	7.67e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOB—coronary artery disease	3.28e-05	7.64e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CXCL8—coronary artery disease	3.26e-05	7.6e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CXCL8—coronary artery disease	3.25e-05	7.58e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOB—coronary artery disease	3.25e-05	7.57e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—JAK2—coronary artery disease	3.25e-05	7.57e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—GSK3B—coronary artery disease	3.24e-05	7.55e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—EDN1—coronary artery disease	3.24e-05	7.55e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—JAK2—coronary artery disease	3.24e-05	7.54e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—EDN1—coronary artery disease	3.23e-05	7.52e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CXCL8—coronary artery disease	3.22e-05	7.51e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—POMC—coronary artery disease	3.21e-05	7.49e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL5—coronary artery disease	3.21e-05	7.49e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CREB1—coronary artery disease	3.21e-05	7.49e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—JAK2—coronary artery disease	3.2e-05	7.47e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—AGT—coronary artery disease	3.2e-05	7.47e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL5—coronary artery disease	3.2e-05	7.46e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—EDN1—coronary artery disease	3.2e-05	7.45e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL5—coronary artery disease	3.17e-05	7.39e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CSF2—coronary artery disease	3.17e-05	7.38e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FGF1—coronary artery disease	3.17e-05	7.38e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FGF1—coronary artery disease	3.16e-05	7.35e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CSF2—coronary artery disease	3.16e-05	7.35e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCL2—coronary artery disease	3.14e-05	7.33e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—LPL—coronary artery disease	3.14e-05	7.32e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APOE—coronary artery disease	3.14e-05	7.32e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6R—coronary artery disease	3.13e-05	7.31e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—LPL—coronary artery disease	3.13e-05	7.3e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CSF2—coronary artery disease	3.12e-05	7.28e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FGF1—coronary artery disease	3.12e-05	7.28e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RPS6KB1—coronary artery disease	3.11e-05	7.26e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MEF2C—coronary artery disease	3.11e-05	7.26e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MEF2C—coronary artery disease	3.1e-05	7.23e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RPS6KB1—coronary artery disease	3.1e-05	7.23e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APOA1—coronary artery disease	3.1e-05	7.23e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—LPL—coronary artery disease	3.1e-05	7.23e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IGF1—coronary artery disease	3.09e-05	7.2e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—MAPK1—coronary artery disease	3.08e-05	7.17e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MEF2C—coronary artery disease	3.07e-05	7.16e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RPS6KB1—coronary artery disease	3.07e-05	7.16e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ITGB3—coronary artery disease	3.03e-05	7.07e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ITGB3—coronary artery disease	3.02e-05	7.05e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ITGB3—coronary artery disease	3e-05	6.98e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CXCL8—coronary artery disease	2.96e-05	6.9e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CXCL8—coronary artery disease	2.95e-05	6.88e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PPP2CA—coronary artery disease	2.95e-05	6.87e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—PIK3CA—coronary artery disease	2.94e-05	6.85e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PPP2CA—coronary artery disease	2.94e-05	6.85e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SERPINE1—coronary artery disease	2.94e-05	6.84e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CXCL8—coronary artery disease	2.92e-05	6.82e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PPP2CA—coronary artery disease	2.91e-05	6.78e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PRKCD—coronary artery disease	2.89e-05	6.75e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PRKCD—coronary artery disease	2.89e-05	6.73e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PRKCD—coronary artery disease	2.86e-05	6.66e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—FGF2—coronary artery disease	2.84e-05	6.62e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HTR2A—coronary artery disease	2.83e-05	6.6e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—C3—coronary artery disease	2.83e-05	6.59e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HTR2A—coronary artery disease	2.82e-05	6.58e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—C3—coronary artery disease	2.82e-05	6.57e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NOS3—coronary artery disease	2.8e-05	6.53e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HTR2A—coronary artery disease	2.8e-05	6.52e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—C3—coronary artery disease	2.79e-05	6.51e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PPARG—coronary artery disease	2.73e-05	6.37e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—JAK2—coronary artery disease	2.72e-05	6.35e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HIF1A—coronary artery disease	2.7e-05	6.29e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—POMC—coronary artery disease	2.7e-05	6.29e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HIF1A—coronary artery disease	2.69e-05	6.27e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AGT—coronary artery disease	2.69e-05	6.26e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AGT—coronary artery disease	2.68e-05	6.24e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—PIK3CA—coronary artery disease	2.67e-05	6.22e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HIF1A—coronary artery disease	2.66e-05	6.21e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AGT—coronary artery disease	2.65e-05	6.18e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOE—coronary artery disease	2.63e-05	6.14e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—LEP—coronary artery disease	2.63e-05	6.14e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—LEP—coronary artery disease	2.63e-05	6.12e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOE—coronary artery disease	2.63e-05	6.12e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOA1—coronary artery disease	2.6e-05	6.07e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—LEP—coronary artery disease	2.6e-05	6.06e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOE—coronary artery disease	2.6e-05	6.06e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOA1—coronary artery disease	2.6e-05	6.05e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—KDR—coronary artery disease	2.58e-05	6.01e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—KDR—coronary artery disease	2.57e-05	5.99e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOA1—coronary artery disease	2.57e-05	5.99e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	2.56e-05	5.97e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MAPK14—coronary artery disease	2.56e-05	5.95e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—KDR—coronary artery disease	2.55e-05	5.94e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	2.53e-05	5.9e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ESR1—coronary artery disease	2.51e-05	5.86e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ESR1—coronary artery disease	2.51e-05	5.84e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CXCL8—coronary artery disease	2.49e-05	5.79e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—F2—coronary artery disease	2.48e-05	5.79e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FN1—coronary artery disease	2.48e-05	5.79e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ESR1—coronary artery disease	2.48e-05	5.78e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FN1—coronary artery disease	2.48e-05	5.77e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—F2—coronary artery disease	2.48e-05	5.77e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	2.47e-05	5.77e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6ST—coronary artery disease	2.47e-05	5.75e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ALB—coronary artery disease	2.46e-05	5.73e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	2.45e-05	5.72e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FN1—coronary artery disease	2.45e-05	5.71e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—F2—coronary artery disease	2.45e-05	5.71e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NFKBIA—coronary artery disease	2.45e-05	5.7e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	2.44e-05	5.69e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	2.42e-05	5.65e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—AKT1—coronary artery disease	2.4e-05	5.6e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CASP3—coronary artery disease	2.38e-05	5.54e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—KIT—coronary artery disease	2.38e-05	5.54e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—KIT—coronary artery disease	2.37e-05	5.52e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL6—coronary artery disease	2.36e-05	5.51e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—NOS3—coronary artery disease	2.35e-05	5.48e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—KIT—coronary artery disease	2.35e-05	5.47e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCND1—coronary artery disease	2.32e-05	5.4e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	2.28e-05	5.32e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GSK3B—coronary artery disease	2.27e-05	5.3e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—POMC—coronary artery disease	2.26e-05	5.27e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CREB1—coronary artery disease	2.26e-05	5.27e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—POMC—coronary artery disease	2.26e-05	5.26e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CREB1—coronary artery disease	2.26e-05	5.26e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	2.25e-05	5.25e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MMP9—coronary artery disease	2.25e-05	5.24e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—POMC—coronary artery disease	2.23e-05	5.21e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CREB1—coronary artery disease	2.23e-05	5.21e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL2—coronary artery disease	2.21e-05	5.16e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6R—coronary artery disease	2.21e-05	5.14e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL2—coronary artery disease	2.21e-05	5.14e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6R—coronary artery disease	2.2e-05	5.13e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL2—coronary artery disease	2.19e-05	5.09e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—AKT1—coronary artery disease	2.18e-05	5.08e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6R—coronary artery disease	2.18e-05	5.08e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IGF1—coronary artery disease	2.18e-05	5.07e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IGF1—coronary artery disease	2.17e-05	5.06e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	2.17e-05	5.05e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—MAPK1—coronary artery disease	2.16e-05	5.03e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PTGS2—coronary artery disease	2.15e-05	5.01e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IGF1—coronary artery disease	2.15e-05	5.01e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	2.14e-05	4.98e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.07e-05	4.82e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	2.07e-05	4.82e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PIK3CA—coronary artery disease	2.06e-05	4.81e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SERPINE1—coronary artery disease	2.06e-05	4.8e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	2.04e-05	4.76e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	2.04e-05	4.75e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—VEGFA—coronary artery disease	2.02e-05	4.71e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FGF2—coronary artery disease	2e-05	4.66e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FGF2—coronary artery disease	1.99e-05	4.65e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FGF2—coronary artery disease	1.97e-05	4.6e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NOS3—coronary artery disease	1.97e-05	4.6e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NOS3—coronary artery disease	1.97e-05	4.58e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NOS3—coronary artery disease	1.95e-05	4.54e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—JAK2—coronary artery disease	1.92e-05	4.47e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—JAK2—coronary artery disease	1.91e-05	4.45e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—JAK2—coronary artery disease	1.89e-05	4.41e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	1.88e-05	4.38e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	1.87e-05	4.37e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	1.86e-05	4.32e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TGFB1—coronary artery disease	1.85e-05	4.32e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MAPK1—coronary artery disease	1.82e-05	4.24e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	1.75e-05	4.08e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	1.74e-05	4.07e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	1.73e-05	4.03e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	1.69e-05	3.94e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	1.69e-05	3.93e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CASP3—coronary artery disease	1.68e-05	3.9e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CASP3—coronary artery disease	1.67e-05	3.89e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	1.67e-05	3.89e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL6—coronary artery disease	1.66e-05	3.88e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL6—coronary artery disease	1.66e-05	3.87e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CASP3—coronary artery disease	1.65e-05	3.85e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL6—coronary artery disease	1.64e-05	3.83e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCND1—coronary artery disease	1.63e-05	3.8e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCND1—coronary artery disease	1.63e-05	3.79e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCND1—coronary artery disease	1.61e-05	3.75e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MMP9—coronary artery disease	1.58e-05	3.69e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MMP9—coronary artery disease	1.58e-05	3.68e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3CA—coronary artery disease	1.58e-05	3.67e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MMP9—coronary artery disease	1.56e-05	3.64e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	1.54e-05	3.58e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	1.53e-05	3.57e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	1.52e-05	3.53e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	1.42e-05	3.31e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	1.42e-05	3.3e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	1.4e-05	3.27e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6—coronary artery disease	1.4e-05	3.25e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CA—coronary artery disease	1.32e-05	3.08e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	1.3e-05	3.04e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	1.3e-05	3.03e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AKT1—coronary artery disease	1.29e-05	3e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	1.29e-05	3e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	1.28e-05	2.98e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	1.28e-05	2.97e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	1.26e-05	2.94e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	1.11e-05	2.59e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	1.11e-05	2.58e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	1.1e-05	2.55e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—AKT1—coronary artery disease	1.08e-05	2.52e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6—coronary artery disease	9.83e-06	2.29e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6—coronary artery disease	9.8e-06	2.28e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6—coronary artery disease	9.71e-06	2.26e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AKT1—coronary artery disease	9.07e-06	2.11e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AKT1—coronary artery disease	9.04e-06	2.11e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AKT1—coronary artery disease	8.95e-06	2.09e-05	CbGpPWpGaD
